SEC Tracker
Get the app

Inovio Pharmaceuticals INO

Inovio Pharmaceuticals amends bylaws

Form
8-K
Filed
Importance
Routine
  1. Effective October 6, 2026
  2. Added Article 12 for exclusive forum
  3. Delaware Chancery Court for fiduciary duty claims
  4. US federal courts for Securities Act cases

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Inovio Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Macrogenics MGNX public float $74M, Jun 30, 2025
  2. Volitionrx VNRX public float $73M, Jun 30, 2025
  3. Gyre Therapeutics GYRE public float $73M, Jun 30, 2025
  4. Oncolytics Biotech ONCY public float $72M, Jun 30, 2025
  5. Seres Therapeutics MCRB public float $72M, Jun 30, 2025